Role of hypoxia-inducible factors in breast cancer metastasis

Gilkes, Daniele M, Semenza, Gregg L·2013·Future Oncology

Cited by (278)

Items 101–200 of 278

  1. Overview of tissue kallikrein and kallikrein-related peptidases in breast cancer
    Carlos D. Figueroa, Luis Molina, Kanti Daya Bhoola, Pamela Ehrenfeld · 2018 · Biological Chemistry
  2. N6-methyladenosine contributes to cellular phenotype in a genetically-defined model of breast cancer progression
    Nate J. Fry, Brittany A. Law, Olga Ilkayeva, Kristen Carraway, Christopher L. Holley, Kyle D. Mansfield · 2018 · Oncotarget
  3. Gain of HIF1 Activity and Loss of miRNA let-7d Promote Breast Cancer Metastasis to the Brain via the PDGF/PDGFR Axis
    Christof B. Wyss, Nathalie Duffey, Sanam Peyvandi, David Barras, Amaia Martínez-Usatorre, Oriana Coquoz, Pedro J. Romero, Mauro Delorenzi, Girieca Lorusso, Curzio Rüegg · 2021 · Cancer Research
  4. The Effects of αvβ3 Integrin Blockage in Breast Tumor and Endothelial Cells under Hypoxia In Vitro
    B. C. Casali, L. T. Gozzer, M. P. Baptista, W. Altei, H. Selistre-de-Araújo · 2022 · International Journal of Molecular Sciences
  5. RETRACTED: Hypoxia induced E-cadherin involving regulators of Hippo pathway due to HIF-1α stabilization/nuclear translocation in bone metastasis from breast carcinoma
    Paola Maroni, Emanuela Matteucci, Lorenzo Drago, Giuseppe Banfi, Paola Bendinelli, Maria Alfonsina Desiderio · 2014 · Experimental Cell Research · Retracted
  6. A polyherbal formulation, HC9 regulated cell growth and expression of cell cycle and chromatin modulatory proteins in breast cancer cell lines
    Snehal Suryavanshi, Amit S. Choudhari, Prerna Raina, Ruchika Kaul-Ghanekar · 2019 · Journal of Ethnopharmacology
  7. The Breast Cancer Tumor Suppressor TRIM29 Is Expressed via ATM-dependent Signaling in Response to Hypoxia
    Muzaffer Dükel, William S. Streitfeld, Tsz Ching Chloe Tang, Lindsey R. F. Backman, Lingbao Ai, W. Stratford May, Kevin D. Brown · 2016 · Journal of Biological Chemistry
  8. Hypoxia Inducible Factors Modify Collagen I Fibers in MDA-MB-231 Triple Negative Breast Cancer Xenografts
    Eibhlin S. Goggins, Samata M. Kakkad, Yelena Mironchik, Desmond Jacob, Flonné B. Wildes, Balaji Krishnamachary, Zaver M. Bhujwalla · 2017 · Neoplasia
  9. Exploiting S-nitrosylation for cancer therapy: facts and perspectives
    Salvatore Rizza, Giuseppe Filomeni · 2020 · Biochemical Journal
  10. Post-Hypoxic Cells Promote Metastatic Recurrence after Chemotherapy Treatment in TNBC
    Inês Godet, Mahelet Mamo, Andrea Thurnheer, David Marc Rosen, Daniele M. Gilkes · 2021 · Cancers
  11. Peromyscus as a model of human disease
    Amanda Havighorst, Janet P. Crossland, Hippokratis Kiaris · 2016 · Seminars in Cell and Developmental Biology
  12. Hypoxia Patterns in Primary and Metastatic Prostate Cancer Environments
    Santosh Kumar Bharti, Samata M. Kakkad, Pierre Danhier, Flonné B. Wildes, Marie‐France Penet, Balaji Krishnamachary, Zaver M. Bhujwalla · 2019 · Neoplasia
  13. Epigenetic regulation of breast cancer metastasis
    Chitra Thakur, Yiran Qiu, Aashna S. Pawar, Fei Chen · 2023 · Cancer and Metastasis Reviews
  14. Glyceollins trigger anti-proliferative effects through estradiol-dependent and independent pathways in breast cancer cells
    Sylvain Lecomte, Frédéric Chalmel, François Ferrière, Frédéric Percevault, Nicolas Plu, Christian Saligaut, Claire Surel, Marie Lelong, Théo Efstathiou, Farzad Pakdel · 2017 · Cell Communication and Signaling
  15. Tumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies
    Josh W. DiGiacomo, Daniele M. Gilkes · 2018 · Targeted Oncology
  16. Review: Nanomaterials for Reactive Oxygen Species Detection and Monitoring in Biological Environments
    Gabriel T. Huynh, Vidhishri Kesarwani, Julia A. Walker, Jessica Ellen Frith, Laurence Meagher, Simon R. Corrie · 2021 · Frontiers in Chemistry
  17. Defining the Balance between Regeneration and Pathological Ossification in Skeletal Muscle Following Traumatic Injury
    Owen G. Davies, Yang Liu, Darren J. Player, Neil R. W. Martin, Liam Michael Grover, Mark P. Lewis · 2017 · Frontiers in Physiology
  18. Sanguinarine disrupts the colocalization and interaction of HIF‐1α with tyrosine and serine phosphorylated‐STAT3 in breast cancer
    Qi Su, Jingjing Wang, Mengying Fan, Mohsin Ahmad Ghauri, Asmat Ullah, Bo Wang, Bingling Dai, Yingzhuan Zhan, Dongdong Zhang, Yanmin Zhang · 2020 · Journal of Cellular and Molecular Medicine
  19. RhoB is regulated by hypoxia and modulates metastasis in breast cancer
    Julia A. Ju, Inês Godet, Josh W. DiGiacomo, Daniele M. Gilkes · 2019 · Cancer Reports
  20. Hypoxia differentially regulates estrogen receptor alpha in 2D and 3D culture formats
    Nathan A. Whitman, Zhi-Wei Lin, Rachael M. Kenney, Leonardo Albertini Sanchez, Matthew Ryen Lockett · 2019 · Archives of Biochemistry and Biophysics
  21. ER and PI3K Pathway Activity in Primary ER Positive Breast Cancer Is Associated with Progression-Free Survival of Metastatic Patients under First-Line Tamoxifen
    Anieta M. Sieuwerts, Marcia Alves de Inda, Marcel Smid, Henk van Ooijen, Anja van de Stolpe, John W.M. Martens, Wim Verhaegh · 2020 · Cancers
  22. The Role of BRCA1/2-Mutated Tumor Microenvironment in Breast Cancer
    Svetlana Miklikova, Lenka Trnkova, Jana Plavá, Martin Boháč, Marcela Kuniaková, Marina Cihova · 2021 · Cancers
  23. Oxygen as a chemoattractant: confirming cellular hypoxia in paper-based invasion assays
    Andrew S. Truong, Matthew Ryen Lockett · 2016 · The Analyst
  24. Metabolic consequences of HIF silencing in a triple negative human breast cancer xenograft
    Santosh Kumar Bharti, Yelena Mironchik, Flonné B. Wildes, Marie‐France Penet, Eibhlin S. Goggins, Balaji Krishnamachary, Zaver M. Bhujwalla · 2018 · Oncotarget
  25. Intratumor heterogeneity ofHMCN1mutant alleles associated with poor prognosis in patients with breast cancer
    Chie Kikutake, Minako Yoshihara, Tetsuya Sato, Daisuke Saito, Mikita Suyama · 2018 · Oncotarget
  26. The genomic architecture of metastasis in breast cancer: focus on mechanistic aspects, signalling pathways and therapeutic strategies
    Yogita Chhichholiya, Prabhat Suman, Sandeep Singh, Anjana Munshi · 2021 · Medical Oncology
  27. Hypoxia-mediated regulation of the secretory properties of mitral valve interstitial cells
    Kareem Salhiyyah, Padmini Sarathchandra, Najma Latif, Magdi Habib Yacoub, Adrian H. Chester · 2017 · American Journal of Physiology-Heart and Circulatory Physiology
  28. Dynamism, Sensitivity, and Consequences of Mesenchymal and Stem-Like Phenotype of Cancer Cells
    Petra Gener, Joaquin Seras‐Franzoso, Patricia González‐Callejo, Fernanda Andrade, Diana Fernandes de Sousa Rafael, Francesc Martínez-Trucharte, Sara Montero, Diego Arango, Joan Sayós, Ibane Abasolo et al. · 2018 · Stem Cells International
  29. Role of microRNA in forming breast carcinoma
    Momi Saikia, Sunanda Paul, Supriyo Chakraborty · 2020 · Life Sciences
  30. Re-inforcing the cell death army in the fight against breast cancer
    Clara Oudenaarden, Robert A. H. van de Ven, Patrick W.B. Derksen · 2018 · Journal of Cell Science
  31. Long Noncoding RNA HCG18 Promotes Malignant Phenotypes of Breast Cancer Cells via the HCG18/miR-103a-3p/UBE2O/mTORC1/HIF-1α–Positive Feedback Loop
    Xu Liu, Kun Qiao, Kaiyuan Zhu, Xianglan Li, Chunbo Zhao, Jiaqi Li, Dawei Feng, Fang Yu, Peng Wang, Cheng Qian et al. · 2021 · Frontiers in Cell and Developmental Biology
  32. 1H-NMR metabolomics analysis identifies hypoxanthine as a novel metastasis-associated metabolite in breast cancer
    Sarra B. Shakartalla, Naglaa S. Ashmawy, Mohammad Harb Semreen, Bahgat E. Fayed, Zainab Al Shareef, Manju Nidagodu Jayakumar, Saleh Mohamed Ibrahim, Mohamed Rahmani, Rania Hamdy, Sameh S. M. Soliman · 2024 · Scientific Reports
  33. Plumbagin Suppresses Breast Cancer Progression by Downregulating HIF-1α Expression via a PI3K/Akt/mTOR Independent Pathway under Hypoxic Condition
    Supawan Jampasri, Somrudee Reabroi, Duangjai Tungmunnithum, Warisara Parichatikanond, Darawan Pinthong · 2022 · Molecules
  34. Hypoxia-induced ATF3 escalates breast cancer invasion by increasing collagen deposition via P4HA1
    S. Dhamdhere, A. Bansal, Pranjal Singh, Parik Kakani, Shruti Agrawal, A. Samaiya, Sanjeev Shukla · 2025 · Cell Death and Disease
  35. Quantification of hypoxia-related gene expression as a potential approach for clinical outcome prediction in breast cancer
    Abderrahim El Guerrab, Anne Cayre, Fabrice Kwiatkowski, Maud Privat, Jean-Marc Rossignol, Fabrice Rossignol, Frederique Madeleine Penault-Llorca, Yves‐Jean Bignon · 2017 · PLoS ONE
  36. MicroRNA-18a regulates the metastatic properties of oral squamous cell carcinoma cells via HIF-1α expression
    Shihyun Kim, Suyeon Park, Ji-Hyeon Oh, Sang Shin Lee, Yoon Min Lee, Jongho Choi · 2022 · BMC Oral Health
  37. Understanding the role of TNFR2 signaling in the tumor microenvironment of breast cancer
    Ali Mussa, Nor Hayati Ismail, Mahasin Hamid, Mohammad A. I. Al-Hatamleh, Anthony J. Bragoli, Khalid Hajissa, Noor Fatmawati Mokhtar, Rohimah Mohamud, Vuk Uskoković, Rosline Hassan · 2024 · Journal of Experimental & Clinical Cancer Research
  38. Current insights and future perspectives of hypoxia-inducible factor-targeted therapy in cancer
    Thekkuttuparambil Ananthanarayanan Ajith · 2018 · Journal of Basic and Clinical Physiology and Pharmacology
  39. Generating linear oxygen gradients across 3D cell cultures with block-layered oxygen controlled chips (BLOCCs)
    Matthew W. Boyce, William C. Simke, Rachael M. Kenney, Matthew Ryen Lockett · 2019 · Analytical Methods
  40. A Network Pharmacology Study on the Molecular Mechanisms of FDY003 for Breast Cancer Treatment
    Ho-Sung Lee, In-Hee Lee, Kyungrae Kang, Sang‐In Park, Seung-Joon Moon, Chol Hee Lee, Dae-Yeon Lee · 2021 · Evidence-based Complementary and Alternative Medicine
  41. Targeting hypoxia regulated sodium driven bicarbonate transporters reduces triple negative breast cancer metastasis
    Christopher Carroll, Hannah R. Bolland, Eric Vancauwenberghe, Pamela Collier, Alison Ritchie, Philip A. Clarke, Anna M. Grabowska, Adrian Llewellyn Harris, Alan McIntyre · 2022 · Neoplasia
  42. Mitochondrial malic enzyme 2 promotes breast cancer metastasis via stabilizing HIF-1α under hypoxia
    Duo You, Danfeng Du, Xueke Zhao, Xinmin Li, Minfeng Ying, Xun Hu · 2021 · Chinese Journal of Cancer Research
  43. The close interaction between hypoxia-related proteins and metastasis in pancarcinomas
    Andrés López‐Cortés, Lavanya Prathap, Esteban Ortiz‐Prado, Nikolaos C. Kyriakidis, Ángela León Cáceres, Isaac Armendáriz‐Castillo, Antonella Vera-Guapi, Verónica Yumiceba, Katherine Simbaña‐Rivera, Gabriela Echeverría‐Garcés et al. · 2022 · Scientific Reports
  44. Enhancement of immune surveillance in breast cancer by targeting hypoxic tumor endothelium: Can it be an immunological switch point?
    Juvin Ann Thomas, Athira Gireesh Gireesh Moly, Hima Xavier, Priya Suboj, Amit Ladha, Gaurav Gupta, Santosh Kumar Singh, Partha Palit, Suboj Babykutty · 2023 · Frontiers in Oncology
  45. UCA1 Overexpression Promotes Hypoxic Breast Cancer Cell Proliferation and Inhibits Apoptosis via HIF-1α Activation
    Hani Choudhry · 2021 · Journal of Oncology
  46. Brain Microvascular Pericytes—More than Bystanders in Breast Cancer Brain Metastasis
    Danyyl Ippolitov, Leanne Arreza, Maliha Nuzhat Munir, Sabine Hombach‐Klonisch · 2022 · Cells
  47. Protective role of all-trans retinoic acid (ATRA) against hypoxia-induced malignant potential of non-invasive breast tumor derived cells
    Yasamin Al‐Qassab, Silvia Grassilli, Federica Brugnoli, Federica Vezzali, Silvano Capitani, Valeria Bertagnolo · 2018 · BMC Cancer
  48. Expression of placental glycans and its role in regulating peripheral blood NK cells during preeclampsia: a perspective
    Julio César Bueno-Sánchez, Alejandra María Gómez-Gutiérrez, Juan Guillermo Maldonado-Estrada, Juan Carlos Quintana · 2023 · Frontiers in Endocrinology
  49. Bayesian Network Marker Selection via the Thresholded Graph Laplacian Gaussian Prior
    Qingpo Cai, Jian Kang, Tianwei Yu · 2019 · Bayesian Analysis
  50. The regulation of Hypoxia-Inducible Factor-1 (HIF-1alpha) expression by Protein Disulfide Isomerase (PDI)
    Yukino Kobayashi, Ami Oguro, Yuta Hirata, Susumu Imaoka · 2021 · PLoS ONE
  51. LXY6090 – a novel manassantin A derivative – limits breast cancer growth through hypoxia-inducible factor-1 inhibition
    Fangfang Lai, Qian Liu, Xiaoyu Liu, Ming Hua Ji, Ping Xie, Xiaoguang Chen · 2016 · OncoTargets and Therapy
  52. TSGA10 Over Expression Decreases Metastasic and Metabolic Activity by Inhibiting HIF-1 in Breast Cancer Cells
    Mozhgan Jahani, Mohsen Shahlaei, Fatemeh Norooznezhad, Shahram Miraghaee, Leila Hosseinzadeh, Narges Moasefi, Reza Khodarahmi‬, Alireza Farokhi, Azadeh Mahnam, Kamran Mansouri · 2020 · Archives of Medical Research
  53. Roles of Post-Translational Modifications of Transcription Factors Involved in Breast Cancer Hypoxia
    Logan Seymour, Niyogushima Nuru, Kaya R. Johnson, Jennifer Michel Villalpando-Gutierrez, Victor Tochukwu Njoku, Costel C. Darie, Anca-Narcisa Neagu · 2025 · Molecules
  54. First trimester human placental factors induce breast cancer cell autophagy
    Gali Epstein Shochet, Liat Drucker, Metsada Pasmanik‐Chor, Meir Pomeranz, Ami Fishman, Shelly Tartakover Matalon, Michael Lishner · 2015 · Breast Cancer Research and Treatment
  55. Omics Analysis of Chemoresistant Triple Negative Breast Cancer Cells Reveals Novel Metabolic Vulnerabilities
    Dimitris Kordias, Christina E. Kostara, Styliani Papadaki, John Verigos, Eleni Th Bairaktari, Angeliki Magklara · 2022 · Cells
  56. Panoramic photoacoustic computed tomography with learning-based classification enhances breast lesion characterization
    Xin Tong, Cindy Zang Liu, Yilin Luo, Li Lin, Jessica M. Dzubnar, Marta Invernizzi, Stephanie Delos Santos, Yide Zhang, Rui Cao, Peng Cheng Hu et al. · 2025 · Nature Biomedical Engineering
  57. Development and characterization of a recombinant silk network for 3D culture of immortalized and fresh tumor‐derived breast cancer cells
    Caterina Collodet, Kelly Blust, Savvini Gkouma, Emmy Ståhl, Xinsong Chen, Johan Hartman, My Hedhammar · 2023 · Bioengineering & Translational Medicine
  58. Nitric Oxide-Scavenging, Anti-Migration Effects, and Glycosylation Changes after Hemin Treatment of Human Triple-Negative Breast Cancer Cells: A Mechanistic Study
    Amir Mohammed Alsharabasy, Amal Aljaabary, Raghvendra Ashok Bohara, Pau Farràs, Sharon Anneve Glynn, Abhay S. Pandit · 2023 · ACS Pharmacology & Translational Science
  59. Opening LOX to metastasis
    Neta Erez · 2015 · Nature
  60. PLC‐β2 is modulated by low oxygen availability in breast tumor cells and plays a phenotype dependent role in their hypoxia‐related malignant potential
    Federica Brugnoli, Silvia Grassilli, Yasamin Al‐Qassab, Silvano Capitani, Valeria Bertagnolo · 2016 · Molecular Carcinogenesis
  61. Targeting tumor hypoxia and hypoxia-inducible factors (HIFs) for the treatment of cancer- A story of transcription factors with novel approach in molecular medicine
    Sukhes Mukherjee, Suman Kumar Ray · 2022 · Current Molecular Medicine
  62. The Hypoxic Response Expression as a Survival Biomarkers in Treatment-Naive Advanced Breast Cancer
    Irwan Gunawan, Mochammad Hatta, Andi Fachruddin Benyamin, Andi Asadul Islam · 2020 · Asian Pacific Journal of Cancer Prevention
  63. Angiogenesis regulation by microRNAs and long non-coding RNAs in human breast cancer
    Zhi Xiong Chong, Swee Keong Yeap, Wan Yong Ho · 2021 · Pathology - Research and Practice
  64. Metastatic Breast Cancer, Organotropism and Therapeutics: A Review
    Ajaz Ahmad Waza, Najeebul Tarfeen, Sabhiya Majid, Yasmeena Hassan, Rashid Mir, Mohd Younis Rather, Naseer Ue Din Shah · 2021 · Current Cancer Drug Targets
  65. Distinct mRNAs in Cancer Extracellular Vesicles Activate Angiogenesis and Alter Transcriptome of Vascular Endothelial Cells
    Pan Zhang, Su Bin Lim, Kuan Jiang, Ti Weng Chew, Boon Chuan Low, Chwee Teck Lim · 2021 · Cancers
  66. The role of the LOX family in cancer
    Diego Liviu Boaru, Diego De León-Oliva, Oscar Fraile‐Μartinez, Patricia De Castro-Martinez, Cielo García Montero, Connie Ferrara-Coppola, Majd N Michael Alhaddadin, Silvestra Barrena-Blázquez, Cristina De las Peñas-González, Noemí Holgado-Tirado et al. · 2025 · European Journal of Cell Biology
  67. Increased expression of collagen prolyl hydroxylases in ovarian cancer is associated with cancer growth and metastasis.
    Mihae Song, Erica K. Schnettler, Annapoorna Venkatachalam, Yujun Wang, Lisa A. Feldman, Peter A. Argenta, Lorna Rodrı́guez-Rodrı́guez, Sundaram Ramakrishnan · 2023 · PubMed Central
  68. The effects of Berberis vulgaris consumption on plasma levels of IGF-1, IGFBPs, PPAR-γ and the expression of angiogenic genes in women with benign breast disease: a randomized controlled clinical trial
    Saeed Pirouzpanah, Sanaz Asemani, Ali Shayanfar, Behzad Baradaran, Vahid Montazeri · 2019 · BMC Complementary and Alternative Medicine
  69. Hypoxia-Inducible Factor 1A Upregulates HMGN5 by Increasing the Expression of GATA1 and Plays a Role in Osteosarcoma Metastasis
    Enjie Xu, Zhe Ji, Heng Jiang, Tao Lin, Jun Ma, Xuhui Zhou · 2019 · BioMed Research International
  70. Tumor cell intrinsic Toll‐like receptor 4 signaling promotes melanoma progression and metastatic dissemination
    Meri Rogava, Andreas Dominik Braun, Tetje Cornelia van der Sluis, Naveen Shridhar, Thomas Tüting, Evelyn Gaffal · 2021 · International Journal of Cancer
  71. Total synthesis and biological evaluation of 7-hydroxyneolamellarin A as hypoxia-inducible factor-1α inhibitor for cancer therapy
    Guangzhe Li, Yujie Shao, Yue Pan, Yueqing Li, Yang Wang, Liu Wang, Xu Wang, Kun Shao, Shisheng Wang, Naixuan Liu et al. · 2021 · Bioorganic & Medicinal Chemistry Letters
  72. New Supramolecular Hypoxia-Sensitive Complexes Based on Azo-Thiacalixarene
    Farida B. Galieva, Mohamed Khalifa, Zaliya V. Akhmetzyanova, Diana A. Mironova, Бурилов Владимир Александрович, S. Е. Solovieva, Igor S. Antipin · 2023 · Molecules
  73. Identification of a Hypoxia-Related Gene Signature for Predicting Systemic Metastasis in Prostate Cancer
    Haoran Xia, Jianlong Wang, Xiaoxiao Guo, Zhengtong Lv, Jingchao Liu, Qiuxia Yan, Ming Liu, Jianye Wang · 2021 · Frontiers in Cell and Developmental Biology
  74. Advances in Oncoanaesthesia and Cancer Pain
    Mary Ann Thomas · 2021 · Cancer Treatment and Research Communications
  75. In vitro radiosensitization of breast cancer with hypoxia‐activated prodrugs
    Radhika Aiyappa‐Maudsley, Lina Elsalem, Ali I. M. Ibrahim, Klaus Pors, Stewart G. Martin · 2022 · Journal of Cellular and Molecular Medicine
  76. Leveraging hypoxia in triple-negative breast cancer as a promising treatment strategy
    Ketki Bhise, Navnath S. Gavande, Arun K. Iyer · 2023 · Drug Discovery Today
  77. Assessment of hypoxia and oxidative-related changes in a lung-derived brain metastasis model by [64Cu][Cu(ATSM)] PET and proteomic studies
    Jade Fantin, Jérôme Toutain, Elodie Anne Pérès, Benoı̂t Bernay, Sarina Maya Mehani, Charly Hélaine, Mickaël Bourgeois, Carole Brunaud, Laurent Chazalviel, Julien Pontin et al. · 2023 · EJNMMI Research
  78. Redox signalling regulates breast cancer metastasis via phenotypic and metabolic reprogramming due to p63 activation by HIF1α
    Zuen Ren, Malindrie Dharmaratne, Huizhi Liang, Outhiriaradjou Benard, Miriam Morales-Gallego, Kimita Suyama, Viney Kumar, Atefeh Taherian Fard, Ameya S Kulkarni, Michael B. Prystowsky et al. · 2024 · British Journal of Cancer
  79. Exercise affects high-fat diet-stimulated breast cancer metastasis through irisin secretion by altering cancer stem cell properties
    YuJin Lee, SoDam Park, SeungHwa Park, Hye Ji Kwon, Sang Ho Lee, Yuri Kim, Jung‐Hyun Kim · 2024 · Biochemistry and Biophysics Reports
  80. Validation of Perfusion Quantification with 3D Gradient Echo Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using a Blood Pool Contrast Agent in Skeletal Swine Muscle
    Stefan Hindel, Anika Sauerbrey, Marc Maaß, Stefan Maderwald, Marc U Schlamann, Lutz Lüdemann · 2015 · PLoS ONE
  81. Mebendazole Treatment Disrupts the Transcriptional Activity of Hypoxia-Inducible Factors 1 and 2 in Breast Cancer Cells
    Joe, Natalie S., Wang, Yuanfeng, Oza, Harsh H., Godet, Inês, Milki, Nubaira, Riggins, Gregory J., Gilkes, Daniele M. · 2023 · Cancers
  82. Targeting Hypoxia and HIF1α in Triple-Negative Breast Cancer: New Insights from Gene Expression Profiling and Implications for Therapy
    Delong Han, Zeyu Li, Lingjie Luo, Hezhong Jiang · 2024 · Biology
  83. Enzymes in Addressing Hypoxia for Biomaterials Engineering
    Pejman Ghaffari‐Bohlouli, Hafez Jafari, Lei Nie, Ashok K. Kakkar, Amin Shavandi · 2024 · Advanced Healthcare Materials
  84. Differential effects of HIF2α antagonist and HIF2α silencing in renal cancer and sensitivity to repurposed drugs
    Esther Arnaiz, Ana Miar, Esther Bridges, Naveen Prasad, Stephanie B. Hatch, Daniel V. Ebner, Charles Henderson Lawrie, Adrian Llewellyn Harris · 2021 · BMC Cancer
  85. Clinical photoacoustic computed tomography of the human breast in vivo within a single breath hold
    Lin Li, Peng Cheng Hu, Junhui Shi, Konstantin Maslov, Lihong V. Wang, Catherine M. Appleton · 2018 · Photons Plus Ultrasound: Imaging and Sensing
  86. Altered molecular pathways decides the treatment outcome of Hsp90 inhibitors against breast cancer cells
    Naga Gowthami Vykuntham, Sourabh Suran, Satish Siripini, Samu John, Pankaj Kumar, Khanderao Paithankar, Sreedhar Amere Subbarao · 2020 · Toxicology in Vitro
  87. The single N-glycan deletion mutant of soluble ErbB3 protein attenuates heregulin β1-induced tumor progression by blocking of the HIF-1 and Nrf2 pathway
    Rina Takamiya, Motoko Takahashi, Yasuaki Uehara, Shigeru Ariki, Jiro Hashimoto, Yoshihiro Hasegawa, Yoshio Kuroki · 2014 · Biochemical and Biophysical Research Communications
  88. Immunohistochemical prediction of lapatinib efficacy in advanced HER2-positive breast cancer patients
    Renata Duchnowska, for the Central and East European Oncology Group (CEEOG), Piotr Jan Wysocki, Konstanty Korski, Bogumiła Czartoryska-Arłukowicz, Anna Niwińska, Marlena Orlikowska, Barbara S. Radecka, Maciej Studziński, Regina Demlová et al. · 2015 · Oncotarget
  89. Cobalt chloride compromises transepithelial barrier properties of CaCo-2 BBe human gastrointestinal epithelial cell layers
    Katherine M. DiGuilio, Mary Carmen Valenzano, Elizabeth Rybakovsky, James M. Mullin · 2018 · BMC Gastroenterology
  90. In vivo longitudinal and multimodal imaging of hypoxia-inducible factor 1α and angiogenesis in breast cancer
    He-Wen Tang, Hailiang Feng, Ming Wang, Qingli Zhu, Yuqin Liu, Yuxin Jiang · 2019 · Chinese Medical Journal
  91. HNF4A functions as a hepatocellular carcinoma oncogene or tumor suppressor depending upon the AMPK pathway activity status
    Zhaoyu Qin, Yan Li, Xiexiang Shao, Kai Li, Yihe Bai, Bing Wang, Fahan Ma, Wenhao Shi, Lei Song, Aojia Zhuang et al. · 2025 · Cancer Letters
  92. The Mechanism of Adaptation of Breast Cancer Cells to Hypoxia: Role of AMPK/mTOR Signaling Pathway
    Danila Vladimirovich Sorokin, Alexander Mikhailovich Scherbakov, Yakushina Ia, Svetlana E. Semina, Margarita V. Gudkova, Krasil'nikov Ma · 2016 · Bulletin of Experimental Biology and Medicine
  93. 5-FU resistant colorectal cancer cells possess improved invasiveness and βIII-tubulin expression
    Svetlana Akalovich, Anna Portyanko, A. Pundik, Artur Mezheyeuski, Т. М. Дорошенко · 2021 · Experimental Oncology
  94. Onco-Breastomics: An Eco-Evo-Devo Holistic Approach
    Anca-Narcisa Neagu, Danielle Whitham, Pathea Shawnae Bruno, Aneeta Arshad, Logan Seymour, Hailey Morrissiey, Angiolina I. Hukovic, Costel C. Darie · 2024 · International Journal of Molecular Sciences
  95. Quantitative Longitudinal Imaging Reveals that Inhibiting Hedgehog Activity Alleviates the Hypoxic Tumor Landscape
    Tshering D. Lama-Sherpa, Shamik Das, Dominique C. Hinshaw, Sarah C. Kammerud, Patrick N. Song, Heba Allah Alsheikh, Anna G. Sorace, Rajeev S. Samant, Lalita A. Shevde · 2021 · Molecular Cancer Research
  96. Prostate fibroblasts and prostate cancer associated fibroblasts exhibit different metabolic, matrix degradation and PD-L1 expression responses to hypoxia
    Jesús Pacheco‐Torres, Raj Kumar Sharma, Yelena Mironchik, Flonné B. Wildes, William Nathaniel Brennen, Dmitri Artemov, Balaji Krishnamachary, Zaver M. Bhujwalla · 2024 · Frontiers in Molecular Biosciences
  97. Oxygen gradients in tumor tissues implications for breast cancer metastasis – a narrative review
    Emmanuel Ifeanyi Obeagu · 2025 · Annals of Medicine and Surgery
  98. Variable number tandem repeats (VNTRs) as modifiers of breast cancer risk in carriers of BRCA1 185delAG
    Yuan Chun Ding, Aaron W. Adamson, Mehrdad Bakhtiari, Carmina S. Patrick, Jonghun Park, Yael Laitman, Jeffrey N. Weitzel, Vineet Bafna, Eitan Friedman, Susan L. Neuhausen · 2022 · European Journal of Human Genetics
  99. TRPM2-L Participates in the Interleukin-6 Pathway to Enhance Tumor Growth in Prostate Cancer by Hypoxia-Inducible Factor-1α
    Kai Cheng, Qingmei Jia, Christopher Batbatan, Zhihua Guo, Fengtao Cheng · 2023 · Journal of Interferon & Cytokine Research
  100. Hypnosis and music interventions (HMIs) inactivate HIF-1: A potential curative efficacy for cancers and hypertension
    Jing-Zhang Wang, Ling Li, Pan Li-lan, Jianhua Chen · 2015 · Medical Hypotheses